Postal ballot for re-appointment of promoter-CEO Mr. Rajiv Gandhi for 3 years

Management Changes View source PDF Explain this filing

HESTERBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.3%Reaction day

₹1509.90

prior close

₹1529.90

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.3%+0.0% vs market

Pharmaceuticals peers, median of 155sector+0.2%+1.1% vs sector

On the reaction day the stock moved in line with Nifty Microcap 250 and 1.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.3+1.3+0.0+0.2+1.1

Next day

-0.3+0.3-0.6-0.4+0.1

+0.0-0.5+0.5-1.1+1.1

+0.7+2.1-1.4+0.7-0.0

+2.7+3.1-0.4+1.3+1.3

+1.0+2.6-1.6+1.5-0.4

+4.3+0.6+3.7+0.3+4.0

15d

+3.6-1.4+5.0-2.6+6.2

+0.0-6.9+6.9-5.1+5.1

-5.7-7.7+2.0-7.9+2.3

+8.7+7.0+1.8+0.7+8.0

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 155Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Hester Biosciences has issued a postal ballot notice seeking member approval for re-appointment of Mr. Rajiv Gandhi, founder and promoter, as CEO and Managing Director for 3 years from 1 April 2026 to 31 March 2029 as his current term ends 31 March 2026. Proposed gross salary is INR 18 lakh per month, plus 5 percent commission on net profits and perquisites including housing and medical. Total remuneration drawn in FY25 was INR 40.07 million. E-voting runs 8 February to 9 March 2026; results to be declared by 11 March 2026.

Likely market impact

Routine re-appointment of existing promoter-CEO; outcome expected to be approved given promoter holding of about 10.48 percent stake.